Albuminuria is independently associated with preclinical left ventricular systolic dysfunction: The TESEO study

Table 1 Demographic and clinical characteristics of the 193 subjects with type 2 diabetes recruited in the study, mean ± SD

Characteristics	DM2 (n = 193)
Clinical characteristics
Age (year)	60.64 ± 8.11
Male gender (%)	57.0
Diabetes duration (year)	3.84 ± 4.92
BMI (kg/m2)	30.96 ± 5.51
BMI ≥ 30 (%)	52.3
WC (cm)	109.17 ± 11.80
SBP (mmHg)	135.9 ± 16.3
DBP (mmHg)	82.7 ± 9.8
Hypertension (%)	89.6
Smoking status (%)
No smokers	39.4
Active smokers	20.7
Former smokers	39.9
Biochemistry
HbA1c (%)	6.48 ± 1.00
Total cholesterol (mg/dL)	175.74 ± 39.56
LDL-cholesterol (mg/dL)	99.71 ± 34.54
HDL-cholesterol (mg/dL)	51.72 ± 12.72
Triglycerides (mg/dL)	114.8 (86.0-147.0)
ACR (mg/mmol)	1.047 (0.565-1.360)
eGFR (mL/minute/1.73 m2)	87.82 ± 15.87
NTpro-BNP (ng/L)	46.0 (26.0-85.0)
Uric acid (mg/L)	5.45 ± 1.56
Glucose lowering medication (%)
Metformin	85.0
DDP-4 inhibitors	10.9
SGLT-2 inhibitors	23.8
GLP-1 receptor agonists	28.0
Insulin	7.3

Data are expressed as mean ± SD, percentage or geometric mean (25%-75%) for log-transformed data. DM2: Type 2 diabetes; BMI: Body mass index; WC: Waist circumference; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; HbA1c: Glycated haemoglobin A1c; LDL: Low-density lipoprotein; HDL: High-density lipoprotein; eGFR: Estimated glomerular filtration rate; ACR: Albumin-creatinine ratio; NTpro-BNP: N-terminal pro b-type natriuretic peptide; DDP-4: Dipeptidyl peptidase-4; SGLT-2: Sodium-glucose cotransporter-2; GLP-1: Glucagon-like peptide-1.